SUCLA2 Arg407Trp mutation can cause a nonprogressive movement disorder – deafness syndrome

Reem A. Alkhater, Saija Ahonen, Berge A. Minassian

Research output: Contribution to journalArticlepeer-review

1 Scopus citations


SUCLA2 is a component of mitochondrial succinate-CoA ligase and nucleotide diphosphokinase activities. Its absence results in Krebs cycle failure, mitochondrial DNA depletion, and a childhood-fatal encephalomyopathy. We describe a purely neurologic allelic form of the disease consisting of deafness, putamenal hyperintensity on MRI and a myoclonic-dystonic movement disorder unchanging from childhood into, so far, the late fourth decade. We show that succinate supplementation circumvents the Krebs cycle block, but does not correct the neurologic disease. Our patients’ Arg407Trp mutation has been reported in children with (yet) no MRI abnormalities. It remains possible that early succinate supplementation could impact the disease.

Original languageEnglish (US)
Pages (from-to)252-258
Number of pages7
JournalAnnals of Clinical and Translational Neurology
Issue number1
StatePublished - Jan 2021

ASJC Scopus subject areas

  • Neuroscience(all)
  • Clinical Neurology


Dive into the research topics of 'SUCLA2 Arg407Trp mutation can cause a nonprogressive movement disorder – deafness syndrome'. Together they form a unique fingerprint.

Cite this